Navigation Links
NIH Plan Charts Course to Better Treatments and Cure for Most Common Known Genetic Cause of Autism: Fragile X
Date:7/22/2009

WALNUT CREEK, Calif., July 22 /PRNewswire/ -- Fragile X Syndrome (FXS) research is moving closer to finding a cure with the recent approval by The National Institutes of Health (NIH) of a comprehensive plan created by a group of leading scientists, parents and advocates.

The Congressional Fragile X Caucus is convening a Congressional briefing to highlight the work of the NIH's Research Plan on Fragile X Syndrome and Associated Disorders and to celebrate National Fragile X Awareness Day in Washington, DC. Leaders of the NIH and Centers for Disease Control & Prevention (CDC), along with leading Fragile X researchers who were instrumental in the development of the plan, will provide insights on the development of the plan, outline key recommendations, and discuss the plan's future impact on the entire Fragile X research trajectory.

FXS is the most common cause of inherited mental impairment, ranging from learning disabilities to more severe cognitive or intellectual disabilities, and is the most common known, single gene cause of autism or "autistic-like" behaviors. Over the past several years, research programs have made significant advances in the understanding of FXS and the associated disorders of fragile X-associated tremor/ataxia (FXTAS) and fragile X-associated primary ovarian insufficiency (FXPOI).

The report recommends 19 goals and 93 objectives to help shape future research in Fragile X-associated Disorders (FXD). Recommendations range from very basic research to applied policy research. Objectives include studying educational and behavioral interventions, evaluating family support systems, identifying risk factors, and looking at molecular and biological systems.

"Implementing a plan of this scope and depth will be an ongoing process over the next few years," said Don Bailey, Ph.D., distinguished fellow at RTI International (rti.org) and president of the NFXF Board of Directors. "It will require major funding from federal agencies, bright and dedicated researchers who are willing to focus on Fragile X, sustained advocacy, and financial partnerships, but we can see the light at the end of the tunnel. The National Fragile X Foundation fully endorses this plan, and we pledge to work with the NIH and other key partners to make sure that it becomes a living document that truly shapes future research."

Visit fragilex.org for a link to the full plan.


'/>"/>
SOURCE The National Fragile X Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Portico(TM) Systems Charts Another Period of Rapid Growth
2. Heavy metal slips down UK air quality charts
3. Researchers Update Risk-of-Death Charts
4. Hyland Softwares Solution Tops the Charts in Annual Healthcare Best in KLAS Awards
5. Irelands Curam Software Charts New Lead in U.S. Market
6. New Nonprofit Health Consulting Firm Charts Course With Integrated Mind/Body Approaches
7. Carnegie Mellon algorithm charts evolution of genetic networks during fruit fly life cycle
8. New research shows how chronic stress worsens neurodegenerative disease course
9. ABQAURP Announces Certificate Course in Medical Error Prevention
10. Speedier skis on course for World Cup glory
11. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the Los ... article to the newly revamped Cosmetic Town journal section, featuring articles ... procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi says ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... RAPIDS, Mich. (PRWEB) , ... October 12, 2017 ... ... Wellness, has been named one of Michigan’s 2017 Best and Brightest in Wellness® ... and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 12, 2017 AVACEN Medical , Inc. (AVACEN) ... their  2017 New Product Innovation Award for Its fibromyalgia ... and secondary medical device market research by Frost & Sullivan,s ... OTC, drug-free pain relief product, the AVACEN 100, offers a ... fibromyalgia widespread pain. ...
(Date:10/11/2017)... 2017  Caris Life Sciences ® , a leading ... of precision medicine, today announced that St. Jude Medical ... Alliance™ (POA) as its 17 th member. Through ... Crosson Cancer Institute will help develop standards of care ... profiling, making cancer treatment more precise and effective. ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
Breaking Medicine Technology: